VJOncology is committed to improving our service to you

ESMO Breast 2020 | Loss of HER2 after neoadjuvant treatment of HER2+ early BC

VJOncology is committed to improving our service to you

Serafin Morales

Serafin Morales, PhD, University Hospital Arnau de Vilanova, Lleida, Spain, discusses the loss of HER2 after neoadjuvant treatment of HER2+ early breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter